Nuvisan ICB GmbH
Berlin, Berlin, Germany
Purpose
To identify novel chemical starting points against a validated tuberculosis drug target, advancing discovery of new medicines with novel mechanisms to benefit people with tuberculosis in low- and middle-income countries.
Division
Global Health
Date
October 2026
Region Served
GLOBAL
Committed amount
$1,621,020
Grant topic
Discovery and Translational Sciences
Duration (months)
9
Grantee location
Berlin, Berlin, Germany
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.